Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.ngind.com | |
Market Cap | 24.96 Cr. | |
Enterprise Value(EV) | 25.49 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 23.43 | Trailing Twelve Months Ending 2022-09 |
Price-Earning Ratio (PE) | 3.18 | Trailing Twelve Months Ending 2022-09 |
Industry PE | 46.98 | Trailing Twelve Months Ending 2022-09 |
Book Value / Share | 78.03 | Trailing Twelve Months Ending 2022-09 |
Price to Book Value | 0.95 | Calculated using Price: 74.50 |
Dividend Yield | 4.70 | Period Ending 2022-03 |
No. of Shares Subscribed | 0.34 Cr. | 3,350,500 Shares |
FaceValue | 10 | |
Company Profile | ||
The company's principal activity is to provide healthcare and medical services. The company facilitates through the treatments and services like, imaging, cardiology, endoscopy, neurology, pathology, orthopaedics, infertility, surgery, operation theatres, indoor ward and surgery. |
1 Day |
|
-2.93% |
1 Week |
|
-0.45% |
1 Month |
|
-3.89% |
3 Month |
|
-6.72% |
6 Month |
|
+9.51% |
1 Year |
|
+10.60% |
2 Year |
|
+90.10% |
5 Year |
|
-1.83% |
10 Year |
|
+6.58% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 10.66 | 9.97 | 10.63 | 9.81 | 7.18 | 9.86 | 14.44 | 5.04 | 13.41 | |
Return on Capital Employed (%) | 13.62 | 12.93 | 15.93 | 14.33 | 11.81 | 14.94 | 17.80 | 6.57 | 17.19 | |
Return on Assets (%) | 8.03 | 8.32 | 9.10 | 8.17 | 6.35 | 9.59 | 12.71 | 4.38 | 11.96 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 14 | 14 | 14 | 14 | 12 | 11 | 9 | 15 | 24 | 26 | |
Non Curr. Liab. | 0 | 0 | 0 | 0 | -2 | -2 | -2 | -1 | 2 | ||
Curr. Liab. | 3 | 3 | 3 | 3 | 2 | 2 | 5 | 2 | 2 | 3 | |
Minority Int. | |||||||||||
Equity & Liab. | 18 | 17 | 17 | 18 | 12 | 11 | 12 | 16 | 27 | 29 | |
Non Curr. Assets | 15 | 15 | 15 | 15 | 10 | 9 | 9 | 14 | 22 | 23 | |
Curr. Assets | 3 | 2 | 2 | 3 | 2 | 3 | 2 | 3 | 5 | 6 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 18 | 17 | 17 | 18 | 12 | 11 | 12 | 16 | 27 | 29 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
Net Sales | 14 | 15 | 17 | 17 | 17 | 18 | 19 | 12 | 18 | 20 | |
Other Income | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 7 | |
Total Income | 14 | 15 | 17 | 17 | 18 | 18 | 19 | 12 | 20 | 27 | |
Total Expenditure | -11 | -12 | -14 | -15 | -15 | -15 | -16 | -11 | -16 | -17 | |
PBIDT | 3 | 3 | 3 | 3 | 2 | 2 | 3 | 1 | 4 | 10 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Depreciation | -1 | -1 | -1 | -1 | -1 | -1 | -1 | 0 | -1 | -1 | |
Taxation | -1 | -1 | -1 | -1 | -1 | -1 | -1 | 0 | -1 | -1 | |
Exceptional Items | |||||||||||
PAT | 2 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 3 | 8 | |
Adjusted EPS | 5 | 4 | 5 | 4 | 3 | 3 | 4 | 2 | 8 | 23 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 2 | 2 | 2 | 2 | 2 | 2 | 4 | 3 | 1 | -2 | |
Cash Fr. Inv. | -4 | 2 | -1 | -1 | -1 | -2 | -1 | -3 | 2 | 1 | |
Cash Fr. Finan. | 2 | -4 | -2 | -1 | -1 | -2 | -2 | 0 | -3 | 0 | |
Net Change | 0 | 0 | -1 | 0 | 0 | -1 | 1 | 0 | 1 | 0 | |
Cash & Cash Eqvt | 2 | 2 | 1 | 1 | 1 | 0 | 1 | 1 | 2 | 1 |
Fri, 03 Feb 2023
Board Meeting Intimation for Consideration And Approval Of The Un-Audited Standalone Financial Results Of The Company For The Quarter And Nine Months Ended 31St December 2022 For The Financial Year 2022-23. N.G.INDUSTRIES LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 inter alia to consider and approve the Un-audited Standalone Financial Results of the Company for the Quarter and Nine Months ended 31st December 2022 for the Financial Year 2022-23. |
Sat, 07 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 |
Fri, 30 Dec 2022
Closure of Trading Window Closure of Trading Window |
Wed, 08 Feb 2023 |
|
|
|
|
Tue, 07 Feb 2023 |
|